Cargando…
Docetaxel-induced hand foot syndrome: “No dose is a safe dose”
Docetaxel is an important chemotherapeutic agent used in the management of many solid tumors. The most important side effect of this drug is myelosupression. We report a case of carcinoma breast that developed severe hand-foot syndrome at 75 mg/m(2) doses of docetaxel. The exact mechanism of this si...
Autores principales: | Jain, Ankit, Dubashi, Biswajit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356968/ https://www.ncbi.nlm.nih.gov/pubmed/22629102 http://dx.doi.org/10.4103/0976-500X.95534 |
Ejemplares similares
-
L-Asparginase induced cortical venous thrombosis in a patient with acute leukemia
por: Dubashi, Biswajit, et al.
Publicado: (2012) -
Docetaxel-induced Hand and Foot Syndrome in a Patient with Metastatic Breast Carcinoma
por: Gurumurthi, Ravichandran, et al.
Publicado: (2013) -
Hand-foot Syndrome Secondary to Low-dose Docetaxel in a Breast Cancer Patient
por: Kewan, Tariq, et al.
Publicado: (2019) -
Hand-foot syndrome with docetaxel: a five-case series
por: Farhat, Mirna H., et al.
Publicado: (2008) -
Author's reply
por: Dubashi, Biswajit, et al.
Publicado: (2012)